secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001601485-23-000086
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics raises $7M via private placement at $5.81/share to board-affiliated entity
--------------------------------------------------------------------------------

- Private placement of 1,213,000 shares at $5.81 per share to GKCC, LLC, controlled by a board member.
- Gross proceeds of ~$7.0M; net proceeds for pipeline advancement, working capital, and general corporate purposes.
- Closing expected on December 22, 2023, subject to customary conditions.
- Company must file a resale registration statement with SEC by March 31, 2024.
- Securities are unregistered; sold under Section 4(a)(2) and Rule 506 of Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/0001601485-23-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148523000086/angn-20231222.htm
  HTML page:      https://secwatch.observer/filing/0001601485-23-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer